Back
CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging…
High8.8EPSS 2.9%
- Published
- Updated
- Reserved
- Assigned by
- icscert
Description
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| NVDNVD · Modified | 3.0 | High8.8 | CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
- EPSS (exploitation in 30 days)
- 2.9% · top 13% of all CVEs (4 Nov 2026)
Loading the EPSS history…
The list uses the assigner's score when there is one, then CISA's, then NVD's: High 8.8.
Weakness
Affected products
Hospira · Symbiq Infusion System
- affected 3.13 and earlier
References (1)
- https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 (opens in a new tab)x_refsource_MISCx_transferred
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://trackcve.app/cve/CVE-2015-3965)Record last updated .